Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger adjusted quarterly profit on Thursday, driven by ...

Sun Pharma share price dropped after the company posted a mixed bag of results in the March quarter of financial year 2025 ...

India’s largest drugmaker plans a $100 million push into US specialty drugs in FY26, even as it braces for regulatory ...

Sun Pharmaceutical Industries reported a consolidated net profit of ₹2,154 crore in the fourth quarter of FY25, registering a ...

Crypto entrepreneur Justin Sun announced that he’s joining a high-profile dinner with the US President Donald Trump later ...

The team aims to become another must-see regional franchise. A rebuilt roster and potential sale could complicate that.

This post has been updated with further information and a statement from our national content partner.